77 results
Page 3 of 4
6-K
EX-99.1
66zses
22 Nov 22
The agreement signed with Innovimed is over a 5-year period, subject to regulatory approvals
9:18am
6-K
EX-99.1
pir60kaa
10 Nov 22
InspiraTM Technologies Granted Patent by the Israeli Patent Office for Key Safety Component for the INSPIRATM ART System
8:40am
6-K
EX-99.1
ep6re8ax
7 Sep 22
Report of Foreign Private Issuer
9:29am
6-K
EX-99.1
ol8xx2e9065y
11 Aug 22
Inspira™ Technologies Reports Second Quarter 2022 Financial Results
10:07am
6-K
EX-99.1
m36c9xevd45k
11 Jul 22
Report of Foreign Private Issuer
9:29am
6-K
EX-99.1
fj8l9j47mp1a fsm96
7 Jul 22
The agreement signed with Glo-Med Networks for the potential deployment of HYLA™ Blood Sensors over a 3-year period, subject to regulatory approvals
9:16am
6-K
EX-99.1
vr1oiesem i31v
6 Jul 22
HYLA™ blood sensor intends to reduce the need for actual blood samples to be taken from patients
9:07am
6-K
EX-99.1
3hhmf
19 May 22
Inspira™ Technologies Announces First Quarter 2022 Financial Results
9:05am
20-F
5qn863v
31 Mar 22
Annual report (foreign)
4:48pm
6-K
EX-99.1
kc3zam9t5i efr8
3 Feb 22
Inspira Technologies Appointed an Expert in the Field of Artificial Lung as the New Chief Technology Officer (CTO) - Daniella Yeheskely-Hayon PhD
9:06am
6-K
EX-99.1
1n50i1x4
1 Feb 22
Report of Foreign Private Issuer
8:58am
6-K
EX-99.1
9q10ybr6x0w4j708
31 Jan 22
Inspira Technologies Signs a Strategic Agreement in the U.S. to
9:06am
6-K
EX-99.1
upenu24n7n8tonxd8t
28 Jan 22
Inspira Technologies Has Listed an FDA Class I 510(k) Exempt component of the ART system
7:36am
6-K
EX-99.1
jltcxwalc kdah5x
19 Jan 22
Report of Foreign Private Issuer
4:03pm
6-K
EX-99.1
mwbrhz2dua532npexix
6 Jan 22
Report of Foreign Private Issuer
6:47am
6-K
EX-99.2
e0qzkbinnnoayq7r2 3d
20 Dec 21
Report of Foreign Private Issuer
4:05pm
6-K
EX-99.1
ikjk37hl tjha1v
9 Dec 21
Inspira Technologies Signs Strategic Agreement with Innovimed for the Potential Deployment of 1,522 ART Systems in Poland, Czech Republic & Slovakia
7:23am
6-K
EX-99.1
pys65
30 Nov 21
Prof. Fan currently serves as the medical director of the extracorporeal life support program at the Toronto General Hospital
8:34am
6-K
EX-99.1
vs6 gn8eqw
23 Nov 21
Inspira Technologies Announces 2021 Third Quarter Financial Results
8:01am
6-K
EX-99.1
zffzvth60nbadkdq4wl7
23 Nov 21
Report of Foreign Private Issuer
6:09am